Search results for
5187 items
Equality and Human Rights Consultation - NICE TA - Necitumumab for Untreated Advanced or Metastatic, Squamous Non-Small-Cell Lung Cancer.
NICE guidance is designed and developed for the NHS in England and is therefore not automatically applicable to Northern Ireland. On 1 July 2006 the
Equality and Human Rights Consultation - NICE TA - Talimogene Laherparepvec for Treating Metastatic Melanoma
NICE guidance is designed and developed for the NHS in England and is therefore not automatically applicable to Northern Ireland. On 1 July 2006 the
Equality and Human Rights Consultation - NICE TA - Trifluridine with Tipiracil Hydrochloride for Treating Metastatic Colorectal Cancer after Standard Therapy
NICE guidance is designed and developed for the NHS in England and is therefore not automatically applicable to Northern Ireland. On 1 July 2006 the
Equality and Human Rights Consultation - NICE TA - Dinutuximab for Treating High-Risk Neuroblastoma
NICE guidance is designed and developed for the NHS in England and is therefore not automatically applicable to Northern Ireland. On 1 July 2006 the
Equality and Human Rights Consultation - NICE TA - Bosutinib for Previously Treated Chronic Myeloid Leukaemia (Review of TA299)
NICE guidance is designed and developed for the NHS in England and is therefore not automatically applicable to Northern Ireland. On 1 July 2006 the
Equality and Human Rights Consultation - NICE TA - Ramucirumab for previously treated locally advanced or metastatic non-small-cell Lung Cancer
NICE guidance is designed and developed for the NHS in England and is therefore not automatically applicable to Northern Ireland. On 1 July 2006 the
Equality and Human Rights Consultation - NICE TA - Degarelix for treating advanced hormone-dependent Prostate Cancer
NICE guidance is designed and developed for the NHS in England and is therefore not automatically applicable to Northern Ireland. On 1 July 2006 the
Equality and Human Rights Consultation - NICE TA - Adalimumab for treating moderate to severe hidradenitis suppurativa
NICE guidance is designed and developed for the NHS in England and is therefore not automatically applicable to Northern Ireland. On 1 July 2006 the
Equality and Human Rights Consultation - NICE TA - Alirocumab for treating primary hypercholesterolaemia and mixed dyslipidaemia
NICE guidance is designed and developed for the NHS in England and is therefore not automatically applicable to Northern Ireland. On 1 July 2006 the
Equality and Human Rights Consultation - NICE TA - Evolocumab for treating primary hyperlipidaemia and mixed dyslipidaemia
NICE guidance is designed and developed for the NHS in England and is therefore not automatically applicable to Northern Ireland. On 1 July 2006 the
Equality and Human Rights Consultation - NICE TA - Trametinib in combination with dabrafenib for treating advanced (unresectable or metastatic) melanoma.
NICE guidance is designed and developed for the NHS in England and is therefore not automatically applicable to Northern Ireland. On 1 July 2006 the
Equality and Human Rights Consultation - NICE TA - Cabazitaxel for hormone relapsed metastatic prostate cancer treated with docetaxel (review of TA255)
NICE guidance is designed and developed for the NHS in England and is therefore not automatically applicable to Northern Ireland. On 1 July 2006 the
Equality and Human Rights Consultation - NICE TA 98 - Methylphenidate, Atomoxetine and Dexamfetamine for Attention Deficit Hyperactivity Disorder (ADHD) in Children and Adolescents
NICE guidance is designed and developed for the NHS in England and is therefore not automatically applicable to Northern Ireland. On 1 July 2006 the
Equality and Human Rights Consultation - NICE TA 386 - Ruxolitinib for treating disease-related splenomegaly or symptoms in adults with myelofibrosis
NICE guidance is designed and developed for the NHS in England and is therefore not automatically applicable to Northern Ireland. On 1 July 2006 the
Equality and Human Rights Consultation - NICE TA 23 - Temozolomide for the treatment of recurrent malignant glioma (brain cancer)
NICE guidance is designed and developed for the NHS in England and is therefore not automatically applicable to Northern Ireland. On 1 July 2006 the
Equality and Human Rights Consultation - NICE TA - Daclatasvir for Treating Chronic Hepatitis C
NICE guidance is designed and developed for the NHS in England and is therefore not automatically applicable to Northern Ireland. On 1 July 2006 the
NICE Equality Consultation - Clinical Guideline NG220 - Multiple sclerosis in adults: management
NICE guidance is designed and developed for the NHS in England and is therefore not automatically applicable to Northern Ireland. On 1 July 2006 the
NICE Equality Consultation - Clinical Guideline NG215 - Medicines associated with dependence or withdrawal symptoms: safe prescribing and withdrawal management for adults
NICE guidance is designed and developed for the NHS in England and is therefore not automatically applicable to Northern Ireland. On 1 July 2006 the
NICE Equality Consultation - Clinical Guideline NG211 - Rehabilitation after traumatic injury
NICE guidance is designed and developed for the NHS in England and is therefore not automatically applicable to Northern Ireland. On 1 July 2006 the
NICE Equality Consultation - Clinical Guideline NG207 - Inducing labour
NICE guidance is designed and developed for the NHS in England and is therefore not automatically applicable to Northern Ireland. On 1 July 2006 the